Mechanical Pipettes Market Report 2026

The mechanical pipettes market size has grown strongly in recent years. It will grow from $1.38 billion in 2025 to $1.46 billion in 2026 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to growth of biomedical and chemical research labs, adoption of single-channel pipettes in academic research, rising demand from pharmaceutical R&D, expansion of multi-channel pipettes for laboratory automation, increasing focus on laboratory standardization.

The mechanical pipettes market size is expected to see strong growth in the next few years. It will grow to $1.82 billion in 2030 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to growth of genomics and proteomics research, rising demand from clinical diagnostics, adoption in high-throughput drug discovery, development of automated pipetting workflows, expansion in emerging markets for life sciences research. Major trends in the forecast period include rising demand for high-precision single-channel pipettes, expansion of multi-channel pipettes in high-throughput laboratories, adoption of ergonomic and user-friendly pipette designs, growth in contract manufacturing organizations (cmos) for pipette production, increasing use of mechanical pipettes in chemical and biological research.

The anticipated growth of the mechanical pipettes market is expected to be driven by the rising demand for personalized medicine. This approach customizes medical treatment based on individual characteristics such as genetics, lifestyle, and environment, aiming to enhance therapeutic effectiveness and minimize adverse effects. The surge in demand for personalized medicine is fueled by advancements in genomics and biotechnology and a growing acknowledgment of its potential to improve treatment outcomes and reduce side effects. Mechanical pipettes play a crucial role in personalized medicine, providing precise liquid handling for genetic testing, biomarker analysis, and the preparation of individualized treatment solutions. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit, reported that the FDA approved 16 new personalized therapies for rare diseases in 2023, up from six in 2022. Consequently, the growing demand for personalized medicine is expected to drive the expansion of the mechanical pipettes market.

Major companies operating in the mechanical pipettes market are concentrating on creating advanced solutions, such as dual-volume selection and ergonomic designs, to improve precision, minimize user fatigue, and streamline workflow efficiency. Dual-volume selection is a feature that enables users to switch quickly between two volume settings, while a volume lock prevents unintended adjustments, ensuring accurate liquid handling in diverse laboratory applications. For example, in August 2023, Eppendorf SE, a Germany-based life sciences company, introduced the Research 3 neo, a mechanical pipette engineered to provide precise and consistent results across various liquid types, tip geometries, and altitudes. Designed with low tip attachment and ejection forces, customizable accessories, and ColorTag marking rings for reversible labeling, the device also features sustainable packaging and compatibility with biobased pipette tips to reduce environmental impact.

In June 2024, NSG Bio Global Pte. Ltd., a Singapore-based provider of co-working laboratory and office space for biotech companies, formed a partnership with Eppendorf SE to enhance research and development capabilities for early-stage biotechnology innovators. Through this collaboration, Eppendorf intends to support biotech startups by offering exclusive access to its laboratory instruments, including mechanical pipettes, consumables, and applications expertise, helping accelerate experimental workflows and boost scientific productivity. Eppendorf SE, a Germany-based life science technology company, is a global manufacturer of laboratory equipment and consumables used in life science research, including pipettes, centrifuges, and bioprocess systems.

Major companies operating in the mechanical pipettes market report are Eppendorf AG, Gilson Inc., Sartorius AG, Thermo Fisher Scientific Inc., Integra Biosciences AG, Hamilton Company, BRAND GMBH + CO KG, Socorex Isba SA, Microlit Industries Private Limited, Accumax Lab Devices Pvt. Ltd., AHN Biotechnologie GmbH, Nichiryo Co. Ltd., CAPP ApS, Vistalab Technologies Inc., Scilogex LLC, Mettler Toledo International Inc., Corning Incorporated, Heathrow Scientific LLC, Hirschmann Laborgeräte GmbH & Co. KG, Vitlab GmbH, Globe Scientific Inc., Dragon Laboratory Instruments Co., Ltd.

North America was the largest region in the mechanical pipettes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mechanical pipettes market are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mechanical pipettes market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mechanical pipettes market consists of sales of fixed-volume pipettes, variable-volume pipettes, and repeat pipettes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.